# clm_616C3B8DE457

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 2,011,800,000 United States dollar  
valid_from: 2024-09-30  
valid_to: 2024-12-31  
published: 2024-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F0F5921A0058  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 2,011,800,000 United States dollar", as of 2024-09-30 (until 2024-12-31). Claim clm_616C3B8DE457, https://asof.is/claim/clm_616C3B8DE457, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm (primary, SEC EDGAR 10-Q Q3 FY2024, published 2024-10-31)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 1,920,700,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_616C3B8DE457](/claim/clm_616C3B8DE457.md) | [clm_B12373EE7B0C](/claim/clm_B12373EE7B0C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.